Literature DB >> 24509910

Two Plasmodium 6-Cys family-related proteins have distinct and critical roles in liver-stage development.

Takeshi Annoura1, Ben C L van Schaijk, Ivo H J Ploemen, Mohammed Sajid, Jing-wen Lin, Martijn W Vos, Avinash G Dinmohamed, Daniel K Inaoka, Sanna R Rijpma, Geert-Jan van Gemert, Severine Chevalley-Maurel, Szymon M Kiełbasa, Fay Scheltinga, Blandine Franke-Fayard, Onny Klop, Cornelus C Hermsen, Kiyoshi Kita, Audrey Gego, Jean-Francois Franetich, Dominique Mazier, Stephen L Hoffman, Chris J Janse, Robert W Sauerwein, Shahid M Khan.   

Abstract

The 10 Plasmodium 6-Cys proteins have critical roles throughout parasite development and are targets for antimalaria vaccination strategies. We analyzed the conserved 6-cysteine domain of this family and show that only the last 4 positionally conserved cysteine residues are diagnostic for this domain and identified 4 additional "6-Cys family-related" proteins. Two of these, sequestrin and B9, are critical to Plasmodium liver-stage development. RT-PCR and immunofluorescence assays show that B9 is translationally repressed in sporozoites and is expressed after hepatocyte invasion where it localizes to the parasite plasma membrane. Mutants lacking B9 expression in the rodent malaria parasites P. berghei and P. yoelii and the human parasite P. falciparum developmentally arrest in hepatocytes. P. berghei mutants arrest in the livers of BALB/c (100%) and C57BL6 mice (>99.9%), and in cultures of Huh7 human-hepatoma cell line. Similarly, P. falciparum mutants while fully infectious to primary human hepatocytes abort development 3 d after infection. This growth arrest is associated with a compromised parasitophorous vacuole membrane a phenotype similar to, but distinct from, mutants lacking the 6-Cys sporozoite proteins P52 and P36. Our results show that 6-Cys proteins have critical but distinct roles in establishment and maintenance of a parasitophorous vacuole and subsequent liver-stage development.

Entities:  

Keywords:  B9; genetically attenuated; liver; malaria; s48/45

Mesh:

Substances:

Year:  2014        PMID: 24509910     DOI: 10.1096/fj.13-241570

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  43 in total

1.  Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites.

Authors:  Maarten van der Velden; Sanna R Rijpma; Vivienne Verweij; Geert-Jan van Gemert; Séverine Chevalley-Maurel; Marga van de Vegte-Bolmer; Blandine M Franke-Fayard; Frans G M Russel; Chris J Janse; Robert W Sauerwein; Jan B Koenderink
Journal:  Am J Trop Med Hyg       Date:  2016-06-13       Impact factor: 2.345

Review 2.  Towards genome-wide experimental genetics in the in vivo malaria model parasite Plasmodium berghei.

Authors:  Joachim M Matz; Taco W A Kooij
Journal:  Pathog Glob Health       Date:  2015-03-19       Impact factor: 2.894

Review 3.  The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle.

Authors:  Silvia A Arredondo; Stefan H I Kappe
Journal:  Int J Parasitol       Date:  2016-11-27       Impact factor: 3.981

Review 4.  Malaria Parasite Liver Infection and Exoerythrocytic Biology.

Authors:  Ashley M Vaughan; Stefan H I Kappe
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

5.  A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice.

Authors:  Ashley M Vaughan; Brandon K Sack; Dorender Dankwa; Nana Minkah; Thao Nguyen; Hayley Cardamone; Stefan H I Kappe
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

6.  Malaria parasites target the hepatocyte receptor EphA2 for successful host infection.

Authors:  Alexis Kaushansky; Alyse N Douglass; Nadia Arang; Vladimir Vigdorovich; Nicholas Dambrauskas; Heather S Kain; Laura S Austin; D Noah Sather; Stefan H I Kappe
Journal:  Science       Date:  2015-11-27       Impact factor: 47.728

Review 7.  The march toward malaria vaccines.

Authors:  Stephen L Hoffman; Johan Vekemans; Thomas L Richie; Patrick E Duffy
Journal:  Vaccine       Date:  2015-08-29       Impact factor: 3.641

Review 8.  The March Toward Malaria Vaccines.

Authors:  Stephen L Hoffman; Johan Vekemans; Thomas L Richie; Patrick E Duffy
Journal:  Am J Prev Med       Date:  2015-12       Impact factor: 5.043

9.  Multidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoites.

Authors:  Sanna R Rijpma; Maarten van der Velden; Maria González-Pons; Takeshi Annoura; Ben C L van Schaijk; Geert-Jan van Gemert; Jeroen J M W van den Heuvel; Jai Ramesar; Severine Chevalley-Maurel; Ivo H Ploemen; Shahid M Khan; Jean-Francois Franetich; Dominique Mazier; Johannes H W de Wilt; Adelfa E Serrano; Frans G M Russel; Chris J Janse; Robert W Sauerwein; Jan B Koenderink; Blandine M Franke-Fayard
Journal:  Cell Microbiol       Date:  2015-11-10       Impact factor: 3.715

Review 10.  The parasitophorous vacuole of the blood-stage malaria parasite.

Authors:  Joachim M Matz; Josh R Beck; Michael J Blackman
Journal:  Nat Rev Microbiol       Date:  2020-01-24       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.